EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

Stoke Therapeutics (STOK) announced alignment with global regulatory agencies on the design of the company’s Phase 3 EMPEROR study of ...

Yunnan Baiyao Group Co. Ltd. A 0.55% ¥107B Tasly Pharmaceutical Group Co. Ltd. A 1.09% ¥21.97B Jiangsu Hengrui Medicine Co. Ltd. A-0.62% ¥293.66B Zhejiang Hisun Pharmaceutical Co. Ltd. A 0.36% ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

Bulk drug parks to promote the domestic production of essential drugs and Promotion of Research & Innovation in the Pharma and MedTech sector (PRIP) scheme along with the promotion of AYUSH as an ...

Sandisk Corporation, the maker of flash drives and memory cards, debuted a new logo today, and it’s based on a single pixel. “It all started with the pixel, which is the fundamental smallest ...

A team of researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a groundbreaking genetic method that leverages a natural bacterial mechanism for the ...

Copyright 2025 The Associated Press. All Rights Reserved. McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its ...

HONG KONG, Dec 13 (Reuters) - Global private equity firms Blackstone (BX.N), opens new tab and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...